Epocrates: A Decade on Top

Podcast

We spoke with Dr. Kent Willyard about his experience using Epocrates since it was introduced to healthcare professionals.

We spoke with Dr. Kent Willyard about his experience using Epocrates since it was introduced to healthcare professionals.

Recent Videos
Brendon Neuen, MBBS, PhD | Credit: X.com
Boadie Dunlop, MD, Weighs in on FDA Advisory Vote on Lykos’ MDMA
HCPLive Five at ADA 2024 | Image Credit: HCPLive
Ralph DeFronzo, MD | Credit: UT San Antonio
Signs and Symptoms of Connective Tissue Disease
Timothy Garvey, MD | Credit: University of Alabama at Birmingham
Atul Malhotra, MD | Credit: Kyle Dykes; UC San Diego Health
Edward V Loftus, Jr, MD | Credit: Mayo Clinic
Connective Tissue Disease Brings Dermatology & Rheumatology Together
A panel of 5 cardiovascular experts
Related Content
Healthy Prenatal Dietary Pattern Linked to Lower Odds of Child Having Autism

Healthy Prenatal Dietary Pattern Linked to Lower Odds of Child Having Autism

Chelsie Derman
July 24th 2024
Article
Health Consequences of Climate Change with Janelle Bludorn, PA-C, MS

Health Consequences of Climate Change with Janelle Bludorn, PA-C, MS

Kevin Kunzmann
July 22nd 2024
Podcast
Improving Schizophrenia Management: A Patient's Call to Care Providers

Improving Schizophrenia Management: A Patient's Call to Care Providers

Chelsie Derman
July 24th 2024
Article
Innovations in GERD: What Vonoprazan (Voquezna) May Offer Over PPIs, with Adelina Hung, MD

Innovations in GERD: What Vonoprazan (Voquezna) May Offer Over PPIs, with Adelina Hung, MD

Abigail Brooks, MA
July 18th 2024
Podcast
Angela Thompson-Paul, MD, MSPH | Credit: LinkedIn

Few Youth Receive Lipid Screening, Highlighting Missed Opportunity to Reduce CVD Risk

Patrick Campbell
July 23rd 2024
Article
Taking Both CYP2D6 Opioids and Antidepressants Leads to Risk for Older Adults

Taking Both CYP2D6 Opioids and Antidepressants Leads to Risk for Older Adults

Chelsie Derman
July 23rd 2024
Article
© 2024 MJH Life Sciences

All rights reserved.